UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~Washington~~WASHINGTON, ~~D.C.~~DC 20549

FORM 8-K

________________________________

CURRENT REPORT

Pursuant to Section 13 ORor 15(d) of the

~~The~~ Securities Exchange Act of 1934

Date of ~~Report~~ ~~(Date of earliest event reported)~~Report: ~~June 18~~November 27, 2007

~~SEQUIAM CORPORATION~~ (~~Exact name~~ Date of earliest ~~registrant~~event ~~as specified in its charter~~reported)

California 333-45678 33-0875030
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)

________________________________

300 Sunport Lane, Orlando, Florida	32809
(Address of principal executive offices)	(Zip Code)

SEQUIAM CORPORATION

~~Registrant’s~~(Exact ~~telephone~~ Name ~~number,~~of ~~including~~Registrant ~~area~~as ~~code: (407~~Specified in Charter) ~~541-0773~~

~~____________________________________________________________________________________________________________ (Former name or former address, if changed since last report.)~~________________________________

California	333-45678	33-0875030
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

300 Sunport Lane

Orlando, Florida 32809

(Address of Principal Executive Offices)

(407) 541-0773

(Registrant's telephone number, including area code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SECTION 2 1 – ~~FINANCIAL~~ ~~INFORMATION~~REGISTRANT’S BUSINESS AND OPERATIONS

Item 21.0401. Entry ~~Triggering~~into ~~Events That Accelerate or Increase~~ a ~~Direct Financial Obligation~~Material orDefinitive ~~an Obligation under an Off-Balance Sheet Arrangement~~Agreement.

OnEffective ~~June~~November 181, 2007, Sequiam ~~Corporation (the~~Biometrics, ~~“Company”)~~Inc., ~~received~~ a ~~written~~wholly-owned ~~notice (the~~subsidiary ~~“Notice”)~~of ~~from~~Sequiam ~~Biometrics~~Corporation ~~Investors, LLC~~ (“~~Biometrics~~Sequiam”) ~~that the Company violated the Subordination Agreement~~, ~~dated~~entered ~~March~~into ~~30,~~a ~~2007,~~one-year byExclusive ~~and~~Product ~~among~~License ~~Mark~~and ~~Mroczkowski,~~Engineering ~~Nick~~Services ~~VandenBrekel~~Agreement ~~and Biometrics~~ (the “~~Subordination~~ Agreement”) ~~because~~with ~~the Company~~Tacoma ~~paid a~~Technology, ~~debt owed to Mr~~Inc. VandenBrekel that was classified as a “Junior Liability”. According to the Notice, the Company’s violation of the Subordination Agreement constituted an event of default under Section 14(~~b) of the Agreement, dated March 30, 2007, between the Company and Biometrics (the~~ “~~Loan Agreement~~Tacoma”)~~, unless cured by the Company within the 30 days curative period following the date of the Notice (July 15, 2007)~~. The ~~Subordination~~ ~~Agreement~~purpose ~~was~~of ~~entered into simultaneously with~~ the ~~Loan~~agreement ~~Agreement in connection with the Company borrowing an additional $2,500,000 from Biometrics. The total amount borrowed from Biometrics~~ is ~~currently $5,715,119 (the "Liabilities"). If the Company fails~~ to ~~cure~~govern the ~~default~~manufacturing ~~set forth in the Notice, then Biometrics may (a) accelerate payment of the Liabilities~~ and ~~immediately~~distribution ~~demand payment in the amount~~ of ~~approximately~~Tacoma’s $5products,~~755,000~~ ~~and~~including ~~(b)~~biometric sensor ~~foreclose on substantially all of the assets of the Company~~modules.

OnAs ~~June~~part ~~21,~~of ~~2007,~~ the ~~Company~~agreement, ~~received~~Tacoma angranted ~~additional~~to ~~written~~Sequiam ~~notice~~an ~~(the~~exclusive, ~~“Additional~~nontransferable, ~~Notice”)~~ revocable, ~~from~~worldwide, ~~Biometrics~~royalty-bearing ~~stating~~license ~~that for~~to somanufacture, ~~long~~use, assell ~~Mr.~~or ~~VandenBrekel~~offer for issale inlicensed ~~full~~Tacoma ~~compliance~~products. ~~with~~In ~~the~~addition ~~terms~~Tacoma ofhereby ~~the~~agrees ~~Agreement~~to ~~described~~provide ~~below,~~software ~~Biometrics would~~programming ~~refrain~~and ~~from~~engineering ~~enforcing~~services ~~its rights under the Loan Agreement with respect~~ to ~~the defaults that were identified in the Notice~~Sequiam.

OnIn ~~June 20,~~exchange ~~2007, Nick VandenBrekel and Biometrics entered into an Agreement (the “Agreement”) which provides that Mr. VandenBrekel will purchase 100% of Biometrics~~ for aconsideration ~~purchase price equal to Biometrics’ out of pocket investment~~within ~~plus accrued interest, all costs of~~ the ~~transaction~~agreement, ~~and~~Sequiam ~~all~~shall ~~expenses~~pay ~~incurred by~~to ~~Biometrics~~Tacoma ~~related~~$7,500 toper ~~its~~month ~~investment~~ in ~~the~~license ~~Company (the “Purchase~~fees ~~Price”). Closing is to be no later than August 20, 2007 (the “Closing~~and ~~Date”).~~a ~~The~~royalty ~~Agreement~~of ~~also states that from June 20, 2007 to the Closing Date, Mr~~$0.50 ~~VandenBrekel~~per ~~will~~unit ~~provide 100%~~ of ~~the~~product ~~working~~manufactured ~~capital~~and ~~needed~~sold by ~~the~~Sequiam that ~~Company~~includes asthe ~~determined~~use byof ~~Biometrics.~~the ~~The~~Tacoma ~~Company~~Matching isAlgorithm ~~not~~and ~~a party to this~~related ~~Agreement~~software.

IfThe ~~Mr. VandenBrekel~~Agreement ~~fails~~may tobe ~~fully~~extended ~~fund~~under the ~~Purchase~~same ~~Price~~terms onand orconditions ~~before~~for ~~the Closing~~additional ~~Date~~1-year orperiods ~~fails~~upon to30 ~~provide~~days ~~the~~written ~~working capital required by the Company from June 20, 2007 to the Closing Date, then Mr~~notice. The ~~VandenBrekel~~Agreement ~~will resign his current~~also ~~role~~supersedes and ~~agree~~replaces tothat ~~serve~~earlier ~~the~~agreement ~~Company~~entered ininto ~~any~~effective ~~capacity that Biometrics requires~~April ~~for two years at a fixed salary of $200~~10,~~000 per annum. Additionally, Mr.~~ VandenBrekel will assign to Biometrics the five million stock options granted to him by the Company and eleven million common shares of the Company owned by him. The common shares will be held in escrow and may be returned to Mr. VandenBrekel at the sole discretion of Biometrics at the end of the two-year service period.2006

~~SECTION 8~~ ~~– OTHER~~The Agreement ~~EVENTS~~is furnished as Exhibit 10.1 hereto.

Item 8.01 Other Events.

The information provided in response to Item 2.04 of this Current Report on Form 8-K is hereby incorporated by reference.

SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS

Item 9.01 . Financial Statements and Exhibits.

(a) Financial Statements of ~~Businesses~~Business Acquired.

Not ~~Applicable~~applicable.

(b) Pro Forma Financial Information.

Not ~~Applicable~~applicable.

~~Not Applicable~~10.1 Product License Agreement and Engineering Services Agreement, effective November 1, 2007, by and between Sequiam Biometrics, Inc. and Tacoma Technology, Inc.

(d) Exhibits.

Number Description

10.1 Notice under Loan Agreement dated as of March 30, 2007, between Sequiam Corporation and Biometrics Investors, LLC, dated June 15, 2007

10.2 Notice under Loan Agreement dated as of March 30, 2007, between Sequiam Corporation and Biometrics Investors, LLC, dated June 21, 2007

99.1 Agreement between Nick VandenBrekel and Biometrics Investors, LLC, dated June 20, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	SEQUIAM CORPORATION
	(Registrant)
Date: June 22, 2007
	By: /s/ Mark L. Mroczkowski
	Mark L. Mroczkowski
	Executive Vice President and Chief Financial Officer

SEQUIAM CORPORATION

Date: December 3, 2007 By: /s/ Mark L. Mroczkowski

Name: Mark L. Mroczkowski

Title: Executive Vice President and Chief Financial Officer

Filing Compare · SEQUIAM CORP